EFFICACY OF SECUKINUMAB IN TNFI-NAIVE PATIENTS ACROSS THE AXIAL SPONDYLOARTHRITIS SPECTRUM OVER 52 WEEKS: A POST HOC ANALYSIS OF THE MEASURE AND PREVENT CLINICAL TRIALS-MedSci.cn

EFFICACY OF SECUKINUMAB IN TNFI-NAIVE PATIENTS ACROSS THE AXIAL SPONDYLOARTHRITIS SPECTRUM OVER 52 WEEKS: A POST HOC ANALYSIS OF THE MEASURE AND PREVENT CLINICAL TRIALS

Magrey, M; Walsh, JA; Huang, F; Kameda, H; Wang, J; Herrem, C; Pertel, P; Marzo-Ortega, H